HOMEPostContact Us
Posted January 02. 2013 12:11PM

Manchester-based Boston Therapeutics wins approval for blood glucose moderating supplement trials in France

Click headline or here to open angled item
Manchester, N.H.-based Boston Therapeutics Inc. (OTCQB: BTHE) announced today that France’s Ministry of Health and the East IV Committee of Protection of Persons (Strasbourg) has approved the pharmaceutical company’s blood glucose-moderating dietary supplement for clinical study to test its efficacy and safety for Type II diabetes patients.